CLOSEOUT LETTER
CellEra LLC MARCS-CMS 618209 —
- Delivery Method:
- VIA UNITED PARCEL SERVICE
- Product:
- Medical Devices
- Recipient:
-
Recipient NameRichard E. Moon
-
Recipient TitleChief Financial Officer
- CellEra LLC
1045 Reed Dr, Ste C
Monroe, OH 45050
United States
- Issuing Office:
- Office of Medical Device and Radiological Health Division 1 – East
United States
Dear Mr. Moon:
The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter, CMS# 618209, dated October 20, 2021 for your firm’s Monroe, OH location. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter.
Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means
Sincerely,
/S/
Gina M. Brackett
Director, Compliance Branch
Office of Medical Devices & Radiological Health
Division One - East